Jacques Cretin

530 total citations
9 papers, 328 citations indexed

About

Jacques Cretin is a scholar working on Oncology, Surgery and Reproductive Medicine. According to data from OpenAlex, Jacques Cretin has authored 9 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Surgery and 3 papers in Reproductive Medicine. Recurrent topics in Jacques Cretin's work include Intraperitoneal and Appendiceal Malignancies (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Telomeres, Telomerase, and Senescence (2 papers). Jacques Cretin is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (3 papers), Ovarian cancer diagnosis and treatment (3 papers) and Telomeres, Telomerase, and Senescence (2 papers). Jacques Cretin collaborates with scholars based in France, Belgium and Australia. Jacques Cretin's co-authors include J Charneau, Fabien Subtil, Laurent Teillet, Emmanuel Mitry, Christophe Locher, Jean‐François Seitz, D. Gargot, Mohamed Gasmi, Jean–Louis Jouve and Gilles Breysacher and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and Gynecologic Oncology.

In The Last Decade

Jacques Cretin

9 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacques Cretin France	7	171	86	84	63	60	9	328
L.F.A.G. Massuger Netherlands	11	86 0.5×	29 0.3×	36 0.4×	183 2.9×	84 1.4×	32	474
Tadashi Aoyama Japan	12	142 0.8×	49 0.6×	9 0.1×	91 1.4×	38 0.6×	36	357
Isabella Capodanno Italy	10	203 1.2×	164 1.9×	26 0.3×	61 1.0×	28 0.5×	22	611
Guillaume Beinse France	12	125 0.7×	93 1.1×	22 0.3×	31 0.5×	9 0.1×	33	361
Özlem Erçelep Türkiye	12	175 1.0×	145 1.7×	6 0.1×	22 0.3×	28 0.5×	55	366
Chengyuan Gu China	13	97 0.6×	150 1.7×	22 0.3×	5 0.1×	59 1.0×	50	443
Dany Gholam France	7	119 0.7×	33 0.4×	25 0.3×	10 0.2×	53 0.9×	16	289
Toshiharu Kanai Japan	11	157 0.9×	45 0.5×	7 0.1×	9 0.1×	31 0.5×	31	589
Alain Zannetti France	8	83 0.5×	135 1.6×	9 0.1×	39 0.6×	5 0.1×	15	228
H. Auvray France	8	136 0.8×	61 0.7×	9 0.1×	7 0.1×	21 0.3×	12	347

Countries citing papers authored by Jacques Cretin

Since Specialization

Citations

This map shows the geographic impact of Jacques Cretin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Cretin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Cretin more than expected).

Fields of papers citing papers by Jacques Cretin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Cretin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Cretin. The network helps show where Jacques Cretin may publish in the future.

Co-authorship network of co-authors of Jacques Cretin

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Cretin. A scholar is included among the top collaborators of Jacques Cretin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Cretin. Jacques Cretin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Joly, Florence, Isabelle Ray‐Coquard, Claude El Kouri, et al.. (2018). Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial. Gynecologic Oncology. 152(1). 68–75. 3 indexed citations

Dubray, Bernard, Julia Salleron, S. Guérif, et al.. (2016). Does short-term androgen depletion add to high dose radiotherapy (80 Gy) in localized intermediate risk prostate cancer? Final analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).. Journal of Clinical Oncology. 34(15_suppl). 5021–5021. 20 indexed citations

Falandry, Claire, Béatrice Horard, Éric Legouffe, et al.. (2015). Telomere length is a prognostic biomarker in elderly advanced ovarian cancer patients: a multicenter GINECO study. Aging. 7(12). 1066–1074. 16 indexed citations

Mahner, Sven�, Werner Meier, Andreas du Bois, et al.. (2014). Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial. European Journal of Cancer. 51(3). 352–358. 41 indexed citations

Rouanet, Philippe, Pascal Roger, Emilie Rousseau, et al.. (2014). HER2 overexpression a major risk factor for recurrence in pT1a‐bN0M0 breast cancer: results from a French regional cohort. Cancer Medicine. 3(1). 134–142. 40 indexed citations

Aparicio, Thomas, Jean–Louis Jouve, Laurent Teillet, et al.. (2013). Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients. Journal of Clinical Oncology. 31(11). 1464–1470. 154 indexed citations

Trédan, Olivier, Isabelle Treilleux, Qing Wang, et al.. (2012). Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study. Targeted Oncology. 8(4). 243–251. 32 indexed citations

Falandry, Claire, Béatrice Horard, Jérôme Alexandre, et al.. (2012). Correlation of short telomeres (ST) with vulnerability, toxicity, and early death in elderly AOC patients receiving carboplatin: A multicenter GINECO trial.. Journal of Clinical Oncology. 30(15_suppl). 9011–9011. 3 indexed citations

Weber, B., Alain Lortholary, F. Mayer, et al.. (2009). Pegylated liposomal doxorubicin and carboplatin in late-relapsing ovarian cancer: a GINECO group phase II trial.. PubMed. 29(10). 4195–200. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact